Estimates Revisions BlossomHill Therapeutics, Inc.
Stocks
BLSM
US0951301003
Biotechnology & Medical Research
|
Delayed
Nasdaq
02:13:58 19/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 26.92 USD | +0.37% |
|
+29.05% | - |
| 09:43pm | BlossomHill Therapeutics Q2 Loss Widens | MT |
| 09:14pm | Earnings Flash (BLSM) BlossomHill Therapeutics Posts Q2 Loss $8.75 a Share | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- BLSM Stock
- Consensus BlossomHill Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
